» Articles » PMID: 39035571

Association Between Diagnostic Delays and Spinal Involvement in Human Brucellosis: A Retrospective Case-Control Study

Overview
Date 2024 Jul 22
PMID 39035571
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Spinal involvement is a common but serious complication of human brucellosis. However, information on the risk factors associated with spinal involvement in individuals with brucellosis is limited.

Methods: This retrospective case-control study aimed to determine the potential risk factors associated with spinal complications in inpatients with brucellosis.

Results: During the study period, brucellosis was diagnosed in 377 patients, of whom 108 (28.64%) showed spinal involvement. Those with spinal involvement were significantly older than patients in the control group (mean age [standard deviation], 53.25 [10.48] vs 43.12 [13.84] years, respectively; < .001). The diagnostic delays were significantly longer in patients with spinal involvement than in the control group (mean delay [standard deviation], 11.17 [13.55] vs 6.03 [8.02] weeks; = .001). Age >40 years (odds ratio, 5.42 [95% confidence interval, 2.65-11.05]; < .001) and diagnostic delay >4 weeks (2.94 [1.62-5.35]; < .001) were independently associated with spinal involvement in brucellosis. The lumbar spine at the L3-5 level was the most affected (152 of 249 [61.04%]). Back pain (92 of 108 in case patients vs 21 of 108 in controls; P < .001) and splenomegaly (23 vs 42 of 108, respectively; = .005) differed significantly between the 2 groups.

Conclusions: Age >40 years and diagnostic delay >4 weeks increased the risk of spinal involvement in brucellosis. Therefore, the time from symptom onset to diagnosis should be shortened, using effective measures to reduce spinal involvement risk.

Citing Articles

Tissue infarction secondary to brucellosis: a systematic review of case reports and case series.

Keyvanfar A, Najafiarab H, Mohammadi Z, Falah Tafti M, Talebian N, Tehrani S BMC Infect Dis. 2025; 25(1):203.

PMID: 39934661 PMC: 11818214. DOI: 10.1186/s12879-025-10599-x.

References
1.
Turgut M, Turgut A, Kosar U . Spinal brucellosis: Turkish experience based on 452 cases published during the last century. Acta Neurochir (Wien). 2006; 148(10):1033-44. DOI: 10.1007/s00701-006-0877-3. View

2.
Jiang W, Chen J, Li Q, Jiang L, Huang Y, Lan Y . Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China. BMC Infect Dis. 2019; 19(1):439. PMC: 6528215. DOI: 10.1186/s12879-019-4081-5. View

3.
Colmenero J, Ruiz-Mesa J, Plata A, Bermudez P, Martin-Rico P, Queipo-Ortuno M . Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin Infect Dis. 2008; 46(3):426-33. DOI: 10.1086/525266. View

4.
Qureshi K, Parvez A, Fahmy N, Abdel Hady B, Kumar S, Ganguly A . Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review. Ann Med. 2024; 55(2):2295398. PMC: 10769134. DOI: 10.1080/07853890.2023.2295398. View

5.
Ulu-Kilic A, Karakas A, Erdem H, Turker T, Inal A, Ak O . Update on treatment options for spinal brucellosis. Clin Microbiol Infect. 2013; 20(2):O75-82. DOI: 10.1111/1469-0691.12351. View